Dr. Del Rivero Highlights a Clinical Trial: Antibody Drug Conjugate ADCT-701 • LACNETS

Dr. Del Rivero discusses a new clinical trial, “Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas.“ For more information, visit